Atlas Trials

Low Dose Aprepitant for Patients Receiving Carboplatin

Clinical trial NCT03237611 · TERMINATED

Trial details

NCT number
NCT03237611
Sponsor
Albert Einstein College of Medicine
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Chemotherapy-induced Nausea and Vomiting
Start date
2018-10-30
Primary completion
2021-02-11
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.